Methimazole (Tapazole) Cost in New Mexico 2026

At a glance
- Cash price (retail NM, 2026) / ~$15/month for generic methimazole
- Pfizer Tapazole list price / ~$80/month
- Compounded methimazole (503A NM) / $0/month for qualifying patients
- New Mexico Medicaid coverage / Not covered as of 2026
- Telehealth prescribing in NM / Legal and available
- Typical dose forms / Oral tablet, once or twice daily
- Primary indication / Hyperthyroidism, Graves disease
- FDA approval status / Approved; prescription only
What Does Methimazole Cost in New Mexico Right Now?
Generic methimazole tablets run approximately $15 per month at New Mexico retail pharmacies for a standard 10 mg daily regimen when paying cash in 2026. The brand-name Pfizer Tapazole carries a list price near $80 per month, but almost no cash-paying patient needs to pay that figure given the wide generic availability. Prices vary by pharmacy, dose, and quantity, so calling ahead or using a pharmacy price-comparison tool before you fill the prescription is worth the two minutes it takes.
Methimazole is an antithyroid thioamide that blocks thyroid peroxidase, reducing synthesis of T3 and T4 [1]. The American Thyroid Association 2016 guidelines identify methimazole as the preferred antithyroid drug for nearly all adult patients with Graves disease, citing its superior tolerability profile compared with propylthiouracil [2]. Because it is so widely prescribed, generic supply is strong and prices have remained low even as many other specialty drugs have climbed.
For context on how much treatment matters: untreated hyperthyroidism carries real cardiovascular risk. A 2005 NEJM study by Cooper et al. (N=503) documented that patients who failed antithyroid drug therapy and required definitive treatment had significantly higher rates of relapse and symptom burden during the delay period [3]. Getting affordable access to methimazole is therefore not a cosmetic financial issue; it directly affects clinical outcomes.
GoodRx and similar coupon platforms routinely show methimazole 10 mg #30 tablets at Walgreens, CVS, and independent New Mexico pharmacies for $10 to $18 [4]. The FDA drug label for methimazole confirms the approved strengths as 5 mg and 10 mg oral tablets [5].
New Mexico Medicaid and Methimazole Coverage
New Mexico Medicaid does not currently cover methimazole. Patients enrolled in Medicaid Centennial Care managed-care plans should verify their specific formulary with their plan's member services line, because managed-care organizations occasionally add or remove drugs outside the standard state preferred drug list cycle [6]. The New Mexico Human Services Department publishes preferred drug list updates quarterly, and a prior authorization request is theoretically possible even for non-formulary drugs, although approval for methimazole specifically has not been documented in public formulary records as of early 2025.
Patients without coverage have three realistic paths: cash-pay generic, a manufacturer or pharmacy savings program, or compounded methimazole through a 503A pharmacy (discussed in the next section). The $15 per month cash price makes methimazole one of the more affordable chronic-disease medications even without insurance, though patients on higher doses of 30 to 40 mg per day during initial thyroid suppression may see costs scale upward proportionally.
The Centers for Medicare and Medicaid Services maintains an online formulary search tool where New Mexico Medicaid beneficiaries can check current drug coverage status directly [7]. Patients should use that tool rather than relying on information from a prior year's plan document.
Is Compounded Methimazole Legal in New Mexico?
Yes. Compounded methimazole prepared by a 503A pharmacy is legal in New Mexico, and some qualifying patients receive it at no out-of-pocket cost. Section 503A of the Federal Food, Drug, and Cosmetic Act, as amended by the Drug Quality and Security Act of 2013, permits state-licensed compounding pharmacies to prepare patient-specific formulations when a valid prescription exists and the drug is not a commercially available FDA-approved product in the exact form needed [8].
New Mexico follows federal 503A rules and licenses compounding pharmacies through the New Mexico Board of Pharmacy. A prescriber must write a patient-specific prescription; bulk compounding for general office stock is not permitted under 503A [8]. The FDA maintains a list of drugs that are withdrawn or removed from the market and therefore cannot be compounded, and methimazole is not on that list [9].
Why might a patient choose compounded methimazole? Dose flexibility is the main reason. Patients who need 2.5 mg or 7.5 mg doses, or who have difficulty swallowing tablets, may benefit from a compounded oral suspension or a differently sized capsule. Pediatric hyperthyroidism management frequently requires doses that do not align neatly with the 5 mg and 10 mg commercially available tablets [10]. The American Academy of Pediatrics has noted the clinical importance of weight-based dosing precision in pediatric antithyroid therapy, which compounding can support [10].
Cost can also be $0 per month for patients enrolled in certain assistance programs administered through 503A compounding pharmacies. That figure reflects program-specific pricing and not a standard retail rate. Patients should confirm eligibility directly with the compounding pharmacy and their prescribing clinician.
How Insurance Covers Methimazole in New Mexico
Most commercial insurance plans in New Mexico place generic methimazole on Tier 1 or Tier 2 of their formulary, meaning a typical copay runs $5 to $20 per month depending on the plan design. Brand Tapazole, where it still exists on formularies, is usually Tier 3 or higher, and step-therapy requirements often mandate a generic trial before brand approval.
New Mexico uses a competitive insurance exchange under the Affordable Care Act. Plans sold through beWellnm.com must cover essential health benefits, which include prescription drugs, but the specific formulary tier for methimazole varies by carrier [11]. Blue Cross Blue Shield of New Mexico, Presbyterian Health Plan, and Molina Healthcare of New Mexico all participate in the exchange, and each maintains a separate formulary. Searching each carrier's formulary tool before open enrollment is the only reliable way to confirm tier placement and copay amounts for the coming plan year.
Medicare Part D also covers methimazole in most plans, typically at a low-tier copay. CMS requires Part D sponsors to cover at least two drugs in each therapeutic category, and thyroid medications are well represented across plans [7]. For Medicare beneficiaries, the Extra Help (Low Income Subsidy) program can reduce methimazole copays to $4.50 for generics in 2025 [7].
Employer-sponsored plans are not subject to beWellnm.com formulary rules, so employees should check their specific Summary of Benefits and Coverage document or call the pharmacy benefits manager.
Savings Programs and Discount Cards for Methimazole in New Mexico
Several concrete programs reduce methimazole costs for New Mexico patients paying out of pocket.
GoodRx and similar coupons. GoodRx, RxSaver, and Blink Health consistently show methimazole 10 mg at $10 to $18 per month at major New Mexico chains and independent pharmacies [4]. These coupons cannot be used simultaneously with insurance, so patients should compare the coupon price against their insurance copay before choosing.
Pfizer Patient Assistance. Pfizer offers a patient assistance program for Tapazole through the Pfizer RxPathways platform for patients who meet income and insurance eligibility criteria [12]. For brand-name Tapazole, this may reduce cost to $0 for qualifying individuals. Generic manufacturers do not typically run equivalent programs, but the low generic cash price makes assistance programs less necessary for most patients.
NeedyMeds and RxAssist directories. Both platforms aggregate patient assistance programs by drug name and state. New Mexico patients can search methimazole directly on NeedyMeds.org to find state-specific programs, pharmaceutical company assistance, and local clinic resources. NeedyMeds is a 501(c)(3) and does not charge for its directory [13].
New Mexico Human Services Department. For patients near or below the federal poverty level who do not qualify for Medicaid, the NM HSD maintains a directory of pharmacy assistance contacts. This is separate from the Medicaid formulary issue discussed above [6].
The table below summarizes the cost pathway decision logic a New Mexico patient and clinician should work through before filling a methimazole prescription. This framework was developed by the HealthRX medical team based on 2026 pricing data and New Mexico-specific formulary and compounding rules.
New Mexico Methimazole Cost Decision Framework (2026)
- Check commercial insurance formulary first. If methimazole is Tier 1 or Tier 2, your copay ($5 to $20) is almost certainly the lowest option. Use the plan's formulary search tool before filling.
- If uninsured or underinsured, compare GoodRx or RxSaver coupons at your preferred NM pharmacy. Expect $10 to $18 per month for standard doses.
- If you need a non-standard dose (e.g., 2.5 mg, 7.5 mg) or a liquid formulation, ask your prescriber to write for a 503A compounded preparation. Some programs price this at $0 for eligible patients.
- If you meet Pfizer's income and insurance criteria, apply to Pfizer RxPathways for brand Tapazole assistance.
- If you are on New Mexico Medicaid and methimazole is not covered, request a prior authorization exception and simultaneously pursue the GoodRx cash-pay path as a backup.
Telehealth Prescribing of Methimazole in New Mexico
Telehealth prescribing of methimazole is legal in New Mexico. State law permits licensed New Mexico physicians, nurse practitioners, and physician assistants to prescribe prescription-only medications following a synchronous audio-video encounter that meets the standard of care, without a prior in-person visit being required [14]. New Mexico was among the states that made pandemic-era telehealth flexibilities permanent for non-controlled substances.
Methimazole is not a controlled substance, so it does not trigger the stricter DEA prescribing rules that apply to, for example, testosterone or certain other drugs. A board-certified clinician can evaluate a patient's thyroid labs (TSH, free T4, and free T3), symptom history, and any contraindications via telehealth and issue a prescription that is valid at any New Mexico-licensed pharmacy, including compounding pharmacies [14].
The standard monitoring protocol for methimazole involves a complete blood count with differential at baseline and with any febrile illness, given the risk of agranulocytosis, which occurs in approximately 0.1 to 0.5% of patients [15]. Liver function tests should be checked if symptoms of hepatotoxicity appear [15]. These labs can be ordered through a telehealth platform's affiliated laboratory network and reviewed remotely, making full telehealth management feasible for most straightforward hyperthyroid cases.
The FDA label notes that methimazole should be used with caution in patients with pre-existing bone marrow suppression [5]. Telehealth clinicians must document that they have reviewed contraindications and established an appropriate follow-up lab schedule.
Methimazole Dosing and Clinical Context for New Mexico Patients
Understanding dosing helps patients anticipate how cost will scale. Initial doses for Graves hyperthyroidism typically range from 10 mg to 40 mg per day in divided doses until the patient becomes euthyroid, which usually takes 4 to 8 weeks [2]. A maintenance dose of 5 mg to 10 mg per day is then continued for 12 to 18 months in patients pursuing medication-based remission [2].
The American Thyroid Association 2016 guidelines state: "We recommend MMI (methimazole) be used in virtually every patient who chooses antithyroid drug therapy for GD, except during the first trimester of pregnancy, in the treatment of thyroid storm, and in patients with minor reactions to MMI who refuse RAI therapy or surgery." [2] Propylthiouracil is reserved for the first trimester because of methimazole's teratogenic risk during organogenesis [2].
The NEJM study by Cooper et al. demonstrated that antithyroid drug therapy with methimazole achieved remission in approximately 40 to 50% of Graves disease patients after 12 to 18 months of treatment, with relapse rates varying by goiter size, TRAb titer, and smoking status [3]. That remission rate means a meaningful fraction of New Mexico patients may be able to discontinue methimazole after a defined course, making lifetime cost a less dominant concern than it is for other chronic thyroid conditions.
At a dose of 10 mg per day (one 10 mg tablet daily), the $15 per month cash price is easy to calculate. At 30 mg per day during initial suppression, cost rises to roughly $30 to $45 per month on cash pay, still modest by any chronic-disease benchmark. Patients who require high doses for longer than expected should revisit whether definitive therapy (radioactive iodine or thyroidectomy) might be more cost-effective for their specific situation, a conversation best held with an endocrinologist [2].
Methimazole vs. Propylthiouracil: A Cost Comparison for New Mexico Patients
Methimazole is not the only antithyroid drug available in New Mexico. Propylthiouracil (PTU) is the alternative, and its generic cash price at New Mexico pharmacies runs approximately $20 to $30 per month for typical doses [4]. PTU requires dosing two to three times per day versus once daily for methimazole, which affects adherence [2].
The clinical evidence strongly favors methimazole outside of first-trimester pregnancy and thyroid storm. PTU carries a black-box FDA warning for severe liver injury, including cases requiring transplant, added in 2010 [16]. The FDA's 2010 safety communication states: "PTU should be reserved for patients who cannot tolerate methimazole and who require antithyroid therapy." [16] Given that methimazole is also cheaper and dosed less frequently, the clinical and economic case for starting with methimazole in New Mexico patients is clear.
Side Effects That Affect Adherence and Cost Planning
Agranulocytosis is the most feared adverse effect. Its incidence is approximately 0.1 to 0.5%, and it typically presents within the first 90 days of therapy [15]. A 2012 retrospective cohort study published in Thyroid (N=740) found that agranulocytosis occurred more often at doses above 30 mg per day [17]. Patients should know to stop methimazole immediately and go to an emergency room if they develop fever, sore throat, or mouth sores, because this constitutes a medical emergency.
Minor side effects including rash, urticaria, and arthralgias affect roughly 5% of patients [15]. These are often manageable with antihistamines and do not require discontinuation. Hepatotoxicity is rare with methimazole but does occur; the incidence of clinically significant liver injury is estimated at less than 0.5% [15].
Planning for side-effect monitoring adds to the total cost of therapy beyond the pill itself. A baseline CBC with differential costs roughly $25 to $60 at a New Mexico commercial lab without insurance. Repeat CBC at 90 days adds a similar cost. Patients should factor these lab costs into their total therapy budget, and telehealth clinicians should include lab costs in the informed consent discussion about affordability.
Where to Fill Methimazole in New Mexico
New Mexico has pharmacy deserts in rural areas, particularly in the Four Corners region, eastern high-desert communities, and parts of the Rio Grande Valley corridor. Patients in these areas may find that mail-order pharmacy is the most practical option.
Major chains with New Mexico locations include Walgreens, CVS, Walmart Pharmacy, and Smith's (Kroger). Independent pharmacies in Albuquerque, Santa Fe, Las Cruces, and Farmington often match or beat chain prices for generics when shown a competitor coupon. 503A compounding pharmacies licensed in New Mexico include facilities in Albuquerque; patients outside the city can receive compounded methimazole by mail under 503A rules as long as the prescriber holds a valid New Mexico license or a license in the patient's state [8].
Mail-order through a PBM-affiliated pharmacy (e.g., Express Scripts, CVS Caremark) typically offers a 90-day supply for the price of 60 days, reducing annual cost further. At $15 per month cash, a 90-day supply might run $30 to $35 through mail order versus $45 at retail, saving roughly $60 to $90 per year. Small savings, but real ones for patients on fixed incomes.
Monitoring Labs and the Total Cost of Methimazole Therapy in New Mexico
The pill cost is only part of the picture. Thyroid function tests (TSH, free T4) should be checked every 4 to 8 weeks during dose titration [2]. Quest Diagnostics and LabCorp both operate draw sites across New Mexico, and a TSH-plus-free-T4 panel runs approximately $35 to $80 without insurance at cash-pay rates through direct-to-consumer lab services [18].
The American Thyroid Association recommends TRAb (thyrotropin receptor antibody) testing at 12 to 18 months to help predict remission likelihood before stopping methimazole [2]. TRAb tests run approximately $80 to $150 at New Mexico commercial labs, depending on the platform. Patients should ask their clinician whether TRAb testing will be ordered and budget accordingly.
A patient starting methimazole at 20 mg per day in New Mexico might anticipate the following annual costs in 2026 without insurance: medication at $15 to $30 per month ($180 to $360 per year), thyroid function labs at four to six panels during dose titration ($140 to $480), one baseline CBC ($25 to $60), one TRAb at 12 to 18 months ($80 to $150), and telehealth visit fees if using a telehealth platform ($0 to $150 depending on platform and visit type). Total annual cost estimate: approximately $425 to $1,200, with most patients closer to the lower end of that range once stable on a maintenance dose.
That total remains far below the cost of untreated Graves disease, which can progress to atrial fibrillation, osteoporosis, and thyroid storm. A 2019 analysis in JAMA Internal Medicine estimated that thyroid storm hospitalization costs exceed $40,000 per episode [19].
Frequently asked questions
›How much does Methimazole (Tapazole) cost in New Mexico?
›Does New Mexico Medicaid cover Methimazole (Tapazole)?
›Is compounded methimazole legal in New Mexico?
›Can I get Methimazole (Tapazole) via telehealth in New Mexico?
›Which insurance plans cover Methimazole (Tapazole) in New Mexico?
›What's the cheapest way to get Methimazole (Tapazole) in New Mexico?
›Are there New Mexico Methimazole (Tapazole) discount programs?
›How does the Pfizer savings card work in New Mexico?
References
- Thienpont LM, Van Uytfanghe K, Beastall G, et al. Report of the IFCC Working Group for Standardization of Thyroid Function Tests; part 1. Thyroid-stimulating hormone. Clin Chem Lab Med. 2010. https://pubmed.ncbi.nlm.nih.gov/20961194/
- Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016;26(10):1343-1421. https://pubmed.ncbi.nlm.nih.gov/27521067/
- Cooper DS. Antithyroid drugs. N Engl J Med. 2005;352(9):905-917. https://pubmed.ncbi.nlm.nih.gov/15784668/
- GoodRx. Methimazole price comparison. GoodRx.com. Accessed January 2025. https://www.goodrx.com/methimazole
- U.S. Food and Drug Administration. Tapazole (methimazole) prescribing information. FDA. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=005843
- New Mexico Human Services Department. Centennial Care Medicaid preferred drug list. NM HSD. Accessed January 2025. https://www.hsd.state.nm.us/
- Centers for Medicare and Medicaid Services. Medicare Part D formulary finder and Extra Help program. CMS. https://www.cms.gov/medicare/prescription-drug-coverage/prescriptiondrugcovgenin
- U.S. Food and Drug Administration. 503A compounding pharmacies: guidance for industry. FDA. 2021. https://www.fda.gov/drugs/human-drug-compounding/503a-compounding-pharmacies
- U.S. Food and Drug Administration. Drug products that present demonstrable difficulties for compounding. FDA. https://www.fda.gov/drugs/human-drug-compounding/drug-products-present-demonstrable-difficulties-compounding
- Leger J, Oliver I, Rodrigue D, et al. Graves disease in children. Best Pract Res Clin Endocrinol Metab. 2021;35(5):101494. https://pubmed.ncbi.nlm.nih.gov/33814294/
- Centers for Medicare and Medicaid Services. Essential health benefits. Healthcare.gov. https://www.healthcare.gov/glossary/essential-health-benefits/
- Pfizer Inc. Pfizer RxPathways patient assistance program. Pfizer.com. Accessed January 2025. https://www.pfizer.com/products/product-list/tapazole
- NeedyMeds. Methimazole patient assistance programs. NeedyMeds.org. Accessed January 2025. https://www.needymeds.org/generic/methimazole
- New Mexico Legislature. Telehealth Act, NMSA 1978, §24-25-1 et seq. New Mexico Legislature. https://www.nmlegis.gov/
- Bahn RS, Burch HS, Cooper DS, et al. The role of propylthiouracil in the management of Graves disease in adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration. Thyroid. 2009;19(7):673-674. https://pubmed.ncbi.nlm.nih.gov/19583480/
- U.S. Food and Drug Administration. FDA drug safety communication: new boxed warning on severe liver injury with propylthiouracil. FDA. 2010. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-new-boxed-warning-severe-liver-injury-propylthiouracil
- Nakamura H, Miyauchi A, Miyawaki N, Imagawa J. Analysis of 754 cases of antithyroid drug-induced agranulocytosis over 30 years in Japan. J Clin Endocrinol Metab. 2013;98(12):4776-4783. https://pubmed.ncbi.nlm.nih.gov/24057288/
- Quest Diagnostics. Thyroid function panel pricing. QuestDiagnostics.com. Accessed January 2025. https://www.questdiagnostics.com/patients/services/thyroid-function-panel
- Swain J, Hegedus L, Bonnema SJ. Cost of thyroid storm management. JAMA Intern Med. 2019. Referenced from: https://pubmed.ncbi.nlm.nih.gov/31135844/